History
  • No items yet
midpage
Ingram v. Novartis Pharmaceuticals Corp.
888 F. Supp. 2d 1241
W.D. Okla.
2012
Read the full case

Background

  • This is a pharmaceutical products liability case against NPC for Aredia and Zometa.
  • Plaintiff Linda Ingram, as personal representative, sues for strict liability and negligence.
  • Case was consolidated in MDL and remanded for further proceedings in 2011.
  • Mr. Ingram used Aredia (1999–2003) then Zometa (2003–2004) to treat cancer-related bone issues; died in 2004.
  • Plaintiff alleges ONJ from the drugs and NPC failed to warn adequately before 1999.
  • Court grants NPC’s motion for summary judgment on all claims.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Proximate causation under learned intermediary Ingram’s doctor would have heeded warnings if adequate. Even with warnings, doctor would have prescribed anyway. Proximate causation fails; warnings inadequate cannot be proven to prevent injury.
Adequacy of NPC warning and its impact on causation NPC failed to warn earlier; presumption shifts burden to NPC. Dr. Hussein testified he would have prescribed anyway if warned. Warning adequacy disputed; Elliott presumption not enough to prove causation given Dr. Hussein’s testimony.
Effect of Dr. Hussein’s changing prescribing practices Changes could have prevented injury; timing is 1999. Changes do not negate Dr. Hussein’s 1999 decision to prescribe Aredia. Changes insufficient to establish proximate causation; 1999 duty governs and would not have changed outcome.
Wrongful death claim viability Death causation linked to NPC’s product via expert testimony. No expert link between NPC and death; claim fails. Summary judgment for NPC on wrongful death claim.
Overall viability of all claims Dispute factual issues exist on causation and warning. No genuine issues; proper warnings and causation not shown. NPC entitled to summary judgment on all claims.

Key Cases Cited

  • Eck v. Parke-Davis, 256 F.3d 1013 (10th Cir. 2001) (learned intermediary doctrine, causation burden shift)
  • Stafford v. Wyeth, 411 F. Supp. 2d 1318 (W.D. Okla. 2006) (heeding presumption and proof framework)
  • Edwards v. Basel Pharms., 933 P.2d 298 (Okla. 1997) (learned intermediary duty framework)
  • Woulfe v. Eli Lilly & Co., 965 F. Supp. 1478 (E.D. Okla. 1997) (causation when warning status is contested)
  • Christian v. Gray, 65 P.3d 591 (Okla. 2003) (expert testimony required to prove medical causation)
  • Cone v. Longmont United Hosp. Ass’n., 14 F.3d 526 (10th Cir. 1994) (summary judgment standards; burden on movant and nonmovant)
Read the full case

Case Details

Case Name: Ingram v. Novartis Pharmaceuticals Corp.
Court Name: District Court, W.D. Oklahoma
Date Published: Jul 18, 2012
Citation: 888 F. Supp. 2d 1241
Docket Number: No. CIV-05-913-L
Court Abbreviation: W.D. Okla.